Neovacs S.A. (ALNEV)の価格はいくらですか

Neovacs S.A. (ALNEV)の価格は$0.00047446です

Neovacs S.A. (ALNEV)の時価総額は何ですか

Neovacs S.A. (ALNEV)の時価総額は$82.80です

Neovacs S.A.（ALNEV）株式分割

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

年	株式分割	分割比率	累積分割比率
2025-07-18	1:1000	x0.001	x1.5625E-23
2024-12-05	1:10000	x0.0001	x1.5625E-20
2024-02-06	1:10000	x0.0001	x1.5625E-16
2023-06-05	1:8000	x0.000125	x1.5625E-12
2023-06-02	1:8000	x0.000125	x1.25E-8
2022-02-01	1:10000	x0.0001	x0.0001

年

株式分割

分割比率

累積分割比率

2025-07-18

1:1000

x0.001

x1.5625E-23

2024-12-05

1:10000

x0.0001

x1.5625E-20

2024-02-06

1:10000

x0.0001

x1.5625E-16

2023-06-05

1:8000

x0.000125

x1.5625E-12

2023-06-02

1:8000

x0.000125

x1.25E-8

2022-02-01

1:10000

x0.0001

企業	株式分割の回数	累積分割比率	国
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
Argenx SE ARGX.US	0	-	NL

企業

株式分割の回数

累積分割比率

国